Senores Pharmaceuticals Limited (SENORES.BO)
BSE · INR · Healthcare · Drug Manufacturers - General
₹1,310.30 (+5.05%) as of
Key statistics
- Market cap
- 60.34B
- P/E (TTM)
- 46.15
- Forward P/E
- 26.42
- EPS (TTM)
- 28.39
- Dividend yield
- 0.00%
- 52-week range
- 708.10 – 1,599.55
- Revenue (TTM)
- 6.8B
- Profit margin
- 18.72%
- Analyst target
- ₹1,613.60
- Volume
- 13.37k
About Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, nutritional supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Ahmedabad, India
- Employees
- 368
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.